TJPC(SH:600488) Tong Hua Shun Cai Bao·2025-03-26 11:32Financial Performance - The company reported a net profit of 133 million yuan for the year 2024, representing a year-on-year increase of 13.68% compared to 117 million yuan in 2023 [1] - Basic earnings per share increased to 0.122 yuan from 0.107 yuan, marking a growth of 14.02% [1] - Total revenue decreased to 3.215 billion yuan from 3.783 billion yuan, reflecting a decline of 15.01% [1] - The return on equity rose to 4.45% from 3.95%, indicating a growth of 12.66% [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 65,134,180 shares, accounting for 59.66% of the circulating shares, with a decrease of 274,150 shares compared to the previous period [2] - Tianjin Pharmaceutical Group Co., Ltd. remains the largest shareholder with 55,453,010 shares, representing 50.79% of the total share capital [3] - Morgan Stanley & Co. International PLC entered the top ten shareholders with 206,090 shares [3] Dividend Distribution - The company announced a dividend distribution of 0.98 yuan per share (including tax) [4]